1.59

1.24% -0.02

After Hours: 1.60 0.01 +0.63%

Hookipa Pharma Inc (HOOK)

Overview News Price History Option Chain Financials Discussions Forecast

Hookipa Pharma Inc stock is traded at $1.59, with a volume of 45,751. It is down -1.24% in the last 24 hours and up +67.37% over the past month. HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

Previous Close:

$1.61

Open:

$1.6

24h Volume:

45,751

Relative Volume:

0.41

Market Cap:

$15.57M

Revenue:

$52.16M

Net Income/Loss:

$-48.60M

P/E Ratio:

-0.3681

EPS:

-4.32

Net Cash Flow:

$-77.48M

1W Performance:

+5.30%

1M Performance:

+67.37%

6M Performance:

-36.90%

1Y Performance:

-78.85%

1-Day Range:

$1.51

$1.61

1-Week Range:

$1.48

$1.62

52-Week Range:

$0.721

$9.09

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name

Hookipa Pharma Inc

Sector

Healthcare (1170)

Industry

Biotechnology (667)

Phone

0114318906360

Address

350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY

Employee

Twitter

@HookipaPharma

Next Earnings Date

2024-11-07

Latest SEC Filings

HOOK's Discussions on Twitter

Compare HOOK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOOK Hookipa Pharma Inc	1.59	18.41M	52.16M	-48.60M	-77.48M	-4.32
ONC Beone Medicines Ltd Adr	245.58	26.10B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.05	111.96B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	42.96M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.20	6.39B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.28	63.52B	14.09B	4.50B	2.96B	39.28

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-15-24	Reiterated	RBC Capital Mkts	Outperform
Dec-02-22	Downgrade	BofA Securities	Buy → Underperform
Nov-12-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-08-21	Initiated	Morgan Stanley	Overweight
Nov-03-20	Initiated	Truist	Buy
Oct-26-20	Initiated	JMP Securities	Mkt Outperform
Oct-19-20	Resumed	H.C. Wainwright	Buy
Sep-27-19	Initiated	H.C. Wainwright	Buy
May-13-19	Initiated	BofA/Merrill	Buy
May-13-19	Initiated	RBC Capital Mkts	Outperform

View All

Hookipa Pharma Inc Stock (HOOK) Latest News

May 25, 2025

HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise - marketscreener.com

May 22, 2025

Hookipa stock gains as Gilead eyes assets (HOOK:NASDAQ) - Seeking Alpha

May 22, 2025

Poolbeg Pharma plc (AIM:POLB) Increase of BookBuild Offer - Share Talk

May 22, 2025

May 05, 2025

HOOKIPA Pharma Inc expected to post a loss of $1.04 a shareEarnings Preview - TradingView

May 05, 2025

May 02, 2025

The Significance of Moving Averages in Hookipa Pharma Inc Inc. (HOOK) Price Performance - investchronicle.com

May 02, 2025

Apr 27, 2025

Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - Defense World

Apr 27, 2025

Short Interest in Hookipa Pharma Inc (NASDAQ:HOOK) Drops By 75.2% - The AM Reporter

Apr 27, 2025

Apr 07, 2025

Hookipa Pharma stock hits 52-week low at $0.81 amid sharp decline - Investing.com India

Apr 07, 2025

Mar 31, 2025

Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India

Mar 31, 2025

Mar 21, 2025

Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 21, 2025

Mar 16, 2025

HOOKIPA Pharma to participate in upcoming investor conferences in September - marketscreener.com

Mar 16, 2025

Mar 13, 2025

Hookipa Pharma (HOOK) Expected to Announce Earnings on Thursday - Defense World

Mar 13, 2025

Mar 06, 2025

Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com Australia

Mar 06, 2025

Mar 05, 2025

Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline By Investing.com - Investing.com South Africa

Mar 05, 2025

Feb 28, 2025

HOOKIPA Pharma Inc. SEC 10-K Report - TradingView

Feb 28, 2025

Feb 25, 2025

Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India

Feb 25, 2025

Hookipa Pharma stock hits 52-week low at $1.56 amid downturn By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 23, 2025

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN

Feb 23, 2025

Feb 21, 2025

BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter

Feb 21, 2025

HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia

Feb 21, 2025

Poolbeg slumps as Hookipa merger is called off - pharmaphorum

Feb 21, 2025

Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World

Feb 21, 2025

Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk

Feb 21, 2025

Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors

Feb 21, 2025

Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView

Feb 21, 2025